Dipeptidyl peptidase 8

Description:

Description
  • Accession: Q6V1X1
  • Swissprot: DPP8_HUMAN
  • Organism: Homo sapiens
  • Gene: DPP8
  • Target class: Enzyme

Drug Relations:

anagliptin
anagliptin hydrochloride salt is the active compound Bioactivity details MOA
saxagliptin
inhibits Dipeptidyl Peptidase-4 Bioactivity details MOA
sitagliptin
A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES. Bioactivity details MOA
teneligliptin
A long-acting, orally bioavailable, pyrrolidine-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Teneligliptin may also reduce plasma triglyceride levels through a sustained increase in GLP-1 levels. Bioactivity details MOA
vildagliptin
a potent, selective and orally bio-available dipeptidyl-peptidase IV inhibitor Bioactivity details MOA